Rhythmic theta and delta activity of cortical and hippocampal neuronal networks in genetically or pharmacologically induced N-methyl-d-aspartate receptor hypofunction under urethane anesthesia

Neuroscience

Volumn 237, Issue , 2013, Pages 255-267

  Kiss, T ^a   Feng, J ^a   Hoffmann, W E ^a   Shaffer, C L ^a   Hajos M ^a,b  

^a PFIZER INC   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EEG; Medial prefrontal cortex; Mouse; Rat; Schizophrenia; Theta oscillation

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DELTA RHYTHM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS THETA RHYTHM; MALE; MOUSE; NERVE CELL NETWORK; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; VENTROMEDIAL PREFRONTAL CORTEX; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; BIPHENYL COMPOUNDS; CARRIER PROTEINS; CEREBRAL CORTEX; DELTA RHYTHM; DIZOCILPINE MALEATE; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; THETA RHYTHM; URETHANE;

EID: 84875654653     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.058     Document Type: Article

References (61)

1. Bland B.H., Declerck S., Jackson J., Glasgow S., Oddie S. Septohippocampal properties of N-methyl-d-aspartate-induced theta-band oscillation and synchrony. Synapse (NY) 2007, 61:185-197.
2. Boulay D., Bergis O., Avenet P., Griebel G. The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice. Neuropsychopharmacology 2010, 35:416-427.
3. Buzsaki G. The thalamic clock: emergent network properties. Neuroscience 1991, 41:351-364.
4. Buzsaki G. Theta oscillations in the hippocampus. Neuron 2002, 33:325-340.
5. Clement E.A., Richard A., Thwaites M., Ailon J., Peters S., Dickson C.T. Cyclic and sleep-like spontaneous alternations of brain state under urethane anaesthesia. PloS One 2008, 3:e2004.
6. Duncan G.E., Inada K., Farrington J.S., Koller B.H. Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction. Brain Res 2008, 1221:41-48.
7. Duncan G.E., Moy S.S., Lieberman J.A., Koller B.H. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 2006, 85:481-491.
8. Duncan G.E., Moy S.S., Perez A., Eddy D.M., Zinzow W.M., Lieberman J.A., Snouwaert J.N., Koller B.H. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 2004, 153:507-519.
9. Dzirasa K., Ramsey A.J., Takahashi D.Y., Stapleton J., Potes J.M., Williams J.K., Gainetdinov R.R., Sameshima K., Caron M.G., Nicolelis M.A. Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling. J Neurosci 2009, 29:8215-8224.
10. Ebert B., Mikkelsen S., Thorkildsen C., Borgbjerg F.M. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. Eur J Pharmacol 1997, 333:99-104.
11. Freed W.J., Weinberger D.R., Bing L.A., Wyatt R.J. Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice. Psychopharmacology 1980, 71:291-297.
12. Guadagna S., Bundgaard C., Hovelso N., Volbracht C., Francis P.T., Egebjerg J., Sotty F. Memantine potentiates hippocampal theta oscillations at a therapeutic dose in anesthetized mice: a mechanistic link to its cognitive-enhancing properties. Neuropharmacology 2012, 62:2208-2218.
13. Hajos M., Hoffmann W.E., Kocsis B. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 2008, 63:1075-1083.
14. Hajos M., Hoffmann W.E., Orban G., Kiss T., Erdi P. Modulation of septo-hippocampal Theta activity by GABAA receptors: an experimental and computational approach. Neuroscience 2004, 126:599-610.
15. Hajos M, Scott L, Harvey B, Morozova E, Feng J, Siok CJ, Cogan S, Kocsis B, Hajos-Korcsok E (2009) Modulation of hippocampal theta oscillation via nociceptin opioid peptide receptors: Relevance to cognition. Program No. 723.4/F6. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, 2009. Online.
16. Halene T.B., Ehrlichman R.S., Liang Y., Christian E.P., Jonak G.J., Gur T.L., Blendy J.A., Dow H.C., Brodkin E.S., Schneider F., Gur R.C., Siegel S.J. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 2009, 8:661-675.
17. Harrison P.J., Owen M.J. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003, 361:417-419.
18. Harrison P.J., West V.A. Six degrees of separation: on the prior probability that schizophrenia susceptibility genes converge on synapses, glutamate and NMDA receptors. Mol Psychiatry 2006, 11:981-983.
19. Heale V., Harley C. MK-801 and AP5 impair acquisition, but not retention, of the Morris milk maze. Pharmacol Biochem Behav 1990, 36:145-149.
20. Homayoun H., Jackson M.E., Moghaddam B. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. J Neurophysiol 2005, 93:1989-2001.
21. Huh C.Y., Goutagny R., Williams S. Glutamatergic neurons of the mouse medial septum and diagonal band of Broca synaptically drive hippocampal pyramidal cells: relevance for hippocampal theta rhythm. J Neurosci 2010, 30:15951-15961.
22. Inada K., Farrington J.S., Moy S.S., Koller B.H., Duncan G.E. Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol. J Neural Transm 2007, 114:899-908.
23. Javitt D.C., Spencer K.M., Thaker G.K., Winterer G., Hajos M. Neurophysiological biomarkers for drug development in schizophrenia. Nature reviews 2008, 7:68-83.
24. Jhee S.S., Chappell A.S., Zarotsky V., Moran S.V., Rosenthal M., Kim E., Chalon S., Toublanc N., Brandt J., Coutant D.E., Ereshefsky L. Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects. J Clin Pharmacol 2006, 46:424-432.
25. Jones M.W., Wilson M.A. Theta rhythms coordinate hippocampal-prefrontal interactions in a spatial memory task. PLoS Biol 2005, 3:e402.
26. Kalvass J.C., Maurer T.S. Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos 2002, 23:327-338.
27. Kinney G.G., Patino P., Mermet-Bouvier Y., Starrett J.E., Gribkoff V.K. Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat. J Pharmacol Exp Ther 1999, 291:99-106.
28. Kiss T., Hoffmann W.E., Hajos M. Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia. Int J Neuropsychopharmacol 2011, 14:29-42.
29. Kiss T., Hoffmann W.E., Scott L., Kawabe T.T., Milici A.J., Nilsen E.A., Hajos M. Role of thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity. Front Psychiatry 2011, 2:14.
30. Kittelberger K., Hur E.E., Sazegar S., Keshavan V., Kocsis B. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia. Brain Struct Funct 2011.
31. Kramis R., Vanderwolf C.H., Bland B.H. Two types of hippocampal rhythmical slow activity in both the rabbit and the rat: relations to behavior and effects of atropine, diethyl ether, urethane, and pentobarbital. Exp Neurol 1975, 49:58-85.
32. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
33. Leung L.W., Desborough K.A. APV, an N-methyl-d-aspartate receptor antagonist, blocks the hippocampal theta rhythm in behaving rats. Brain Res 1988, 463:148-152.
34. Li S., Topchiy I., Kocsis B. The effect of atropine administered in the medial septum or hippocampus on high- and low-frequency theta rhythms in the hippocampus of urethane anesthetized rats. Synapse (NY) 2007, 61:412-419.
35. Lipska B.K., Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000, 23:223-239.
36. Majchrzak M.J., Guanowsky V., Freeman J., McLean S., Shaffer C.L., Seymour P.A. Behavioral pharmacology of the AMPA positive allosteric modulators PF-4778574 and LY451646. Soc Neurosci Abstr 2009, 2009(883):18.
37. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 1989, 2:299-308.
38. McNaughton N., Kocsis B., Hajós M. Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?. Behav Pharmacol 2007, 18:329-346.
39. Miller C.L., Bickford P.C., Leybman V.L., Adler L.E., Gerhardt G.A., Freedman R. Phencyclidine and auditory sensory gating in the hippocampus of the rat. Neuropharmacology 1992, 31:1041-1048.
40. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-884.
41. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
42. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego, San Francisco, New York, Boston, London, Sydney, Tokyo.
43. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, New York, NY.
44. Pitkanen M., Sirvio J., Ylinen A., Koivisto E., Riekkinen P. Effects of NMDA receptor modulation on hippocampal type 2 theta activity in rats. General Pharmacol 1995, 26:1065-1070.
45. Roberts B.M., Holden D.E., Shaffer C.L., Seymour P.A., Menniti F.S., Schmidt C.J., Williams G.V., Castner S.A. Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction. Behav Brain Res 2010, 212:41-48.
46. Santana N., Troyano-Rodriguez E., Mengod G., Celada P., Artigas F. Activation of thalamocortical networks by the N-methyl-d-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biol Psychiatry 2011, 69:918-927.
47. Sebban C., Tesolin-Decros B., Ciprian-Ollivier J., Perret L., Spedding M. Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors. Br J Pharmacol 2002, 135:65-78.
48. Sebban C., Tesolin-Decros B., Millan M.J., Spedding M. Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil. Br J Pharmacol 1999, 128:1055-1063.
49. Shaffer C, Scialis R, Lotarski S, Bryce D, Liu J, Majchrzak M, Christoffersen C, Hoffmann W, Campbell B, Hurst R, McLean S, Ganong A, Hajós M, Seymour P, Menniti F, Schmidt C (2009) Defining the mechanism-mediated exposure-response continuum of a novel AMPA receptor potentiator. Program No. 883.17/FF61. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, 2009. Online.
50. Shaffer C.L. Chapter 4 - defining neuropharmacokinetic parameters in cns drug discovery to determine cross-species pharmacologic exposure-response relationships. Annu Rep Med Chem 2010, 45:55-70.
51. Shin J., Kim D., Bianchi R., Wong R.K., Shin H.S. Genetic dissection of theta rhythm heterogeneity in mice. Proc Natl Acad Sci U S A 2005, 102:18165-18170.
52. Siapas A.G., Lubenov E.V., Wilson M.A. Prefrontal phase locking to hippocampal theta oscillations. Neuron 2005, 46:141-151.
53. Sigurdsson T., Stark K.L., Karayiorgou M., Gogos J.A., Gordon J.A. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010, 464:763-767.
54. Siok C.J., Rogers J.A., Kocsis B., Hajos M. Activation of alpha7 acetylcholine receptors augments stimulation-induced hippocampal theta oscillation. Eur J Neurosci 2006, 23:570-574.
55. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am J Psychiatry 2010, 167:1178-1193.
56. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., Coyle J.T. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995, 52:829-836.
57. Ujfalussy B., Kiss T. How do glutamatergic and GABAergic cells contribute to synchronization in the medial septum?. J Comput Neurosci 2006, 21:343-357.
58. Vanderwolf C.H., Robinson T.E. Reticulo-cortical activity and behavior: a critique of the arousal theory and a new synthesis. Behav Brain Sci 1981, 4:459-476.
59. Vertes R.P., Kocsis B. Brainstem-diencephalo-septohippocampal systems controlling the theta rhythm of the hippocampus. Neuroscience 1997, 81:893-926.
60. Wolansky T., Clement E.A., Peters S.R., Palczak M.A., Dickson C.T. Hippocampal slow oscillation: a novel EEG state and its coordination with ongoing neocortical activity. J Neurosci 2006, 26:6213-6229.
61. Zhang Y., Llinas R.R., Lisman J.E. Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting. Front Neural Circuits 2009, 3:20.